GSL, a pharmaceutical company, developed a new drug (Drug C) to lessen the effects of COVID 23. Two drugs (Drug A and Drug B) are already existing in the market that claims the same effect for COVID 23. With this, GSL wants to prove that their new drug is better than the existing ones but they also want to determine the effect of the drug with the vaccine (Vaccine 1 and Vaccine 2) for COVID 23. A study sponsored by GSL was conducted and a total of 30 subjects were included. The three drugs mentioned were given to the subjects and the number of antibodies (T1 No Antibodies) were measured after a week